IMI – Industry Guidelines and Ethical Considerations for Myopia Control Report

Jones, Lyndon; Drobe, Björn; González-Meijóme, José Manuel; Gray, Lyle S.; Kratzer, Timo; Newman, Steve; Nichols, Jason J.; Ohlendorf, Arne; Ramdass, Stephanie; Santodomingo-Rubido, Jacinto; Schmid, Katrina L.; Tan, Donald; Tan, K.T.; Vera-Díaz, Fuensanta A; Wong, Yee-Ling; Gifford, Kate; Resnikoff, Serge

doi:10.1167/iovs.18-25963

Cited by 27 publications

(34 citation statements)

References 173 publications

(233 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Approximately one third of practitioners not adopting myopia control approaches felt them to be uneconomical and/or that there was inadequate information about them; about another one third of respondents suggested that outcomes were unpredictable, the relative safety of these strategies was concerning, myopia control methods were ineffective and/or that the benefit to risk ratio was too low; with some also mentioning the involved additional chair time. Further comments raised the issue of availability of some myopia control options, presumably of novel myopia control lenses, as current approaches are off-label, highlighting the need for regulatory oversight and guidance [8]. Limited access to necessary instrumentation was also raised as a potential barrier, as more advanced contact lens fitting, such as orthokeratology, require the use of corneal topography [9].…”

Section: Discussionmentioning

confidence: 99%

“…Holden et al [1] projected myopia to affect half of the world's population by 2050 and with a propensity to become the leading cause for irreversible blindness. Deeming it a public health concern worldwide, The International Myopia Institute (IMI) released white papers (available online: https:// www.myopiainstitute.org/imi-white-papers.html) synthesizing the latest and complete knowledge surrounding myopia across seven expert committees, including: Myopia Control Reports Overview and Introduction [2]; Defining and Classifying Myopia [3]; Experimental Models of Emmetropization and Myopia [4]; Myopia Genetics [5]; Interventions for Myopia Onset and Progression [6]; Clinical Myopia Control Trials and Instrumentation [7]; Industry Guidelines and Ethical Considerations for Myopia Control [8]; Clinical Myopia Management Guidelines [9].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Global trends in myopia management attitudes and strategies in clinical practice – 2019 Update

Wolffsohn

Calossi

Cho

et al. 2020

Contact Lens and Anterior Eye

Self Cite

View full text Add to dashboard Cite

A survey in 2015 identified a high level of eye care practitioner concern about myopia with a reported moderately high level of activity, but the vast majority still prescribed single vision interventions to young myopes. This research aimed to update these findings 4 years later. Methods: A self-administrated, internet-based questionnaire was distributed in eight languages, through professional bodies to eye care practitioners globally. The questions examined: awareness of increasing myopia prevalence, perceived efficacy of available strategies and adoption levels of such strategies, and reasons for not adopting specific strategies. Results: Of the 1336 respondents, concern was highest (9.0 ± 1.6; p < 0.001) in Asia and lowest (7.6 ± 2.2;

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Global trends in myopia management attitudes and strategies in clinical practice – 2019 Update

Wolffsohn

Calossi

Cho

et al. 2020

Contact Lens and Anterior Eye

Self Cite

View full text Add to dashboard Cite

show abstract

“…During recruitment, it was made clear that no particular previous myopia control experience was required. No new issues were emerging during the second focus group with optometrists in practice, indicating that saturation of ideas had been achieved 17 .…”

Section: Methodsmentioning

confidence: 99%

Is optometry ready for myopia control? Education and other barriers to the treatment of myopia

2019

View full text Add to dashboard Cite

Background: With the increasing prevalence of myopia there is growing interest in active myopia control. However, the majority of progressive myopes are still prescribed single vision spectacles. This prospective study aims to elucidate the knowledge and attitudes of optometrists toward myopia control, and thereby identify perceived barriers to the implementation of a risk focussed model of myopia management. Methods: A series of four focus group discussions were conducted involving optometrists in different settings and career stages. Results: The key finding to emerge is a clear disconnect between academic optometrists, optometry students and clinicians in practice. Academic faculty considered themselves competent in managing progressive myopia and believed the optometry curriculum provides undergraduates with sufficient clinical skills and knowledge to practise myopia control. Final-year optometry students regarded themselves as knowledgeable about myopia control but lack confidence in their ability to practise myopia control, with only one student indicating they would initiate myopia control therapy. The majority of clinicians do not offer myopia control treatments, other than to communicate lifestyle advice to modify risk of myopia progression. Clinicians alluded to a lack of availability of myopia control interventions and identified a range of barriers relating to their training, clinical practice and public health challenges, financial, technological and other constraints that affect the implementation of such interventions. Conclusion: It appears optometrists have to yet embrace myopia control as a core element of the clinical eye care service they provide. Education, training, finance, and time restrictions, as well as limited availability of myopia control therapies were among the main perceived barriers to myopia control. This study revealed a distinct need for alignment between optometric training and the public health need for effective myopia control.

show abstract

“…A range of optical and pharmacological interventions, such as atropine eye drops (at varying concentrations), multifocal contact lenses, orthokeratology and defocus modifying spectacle lenses (DIMS) have been demonstrated to reduce myopia progression when compared with single vision spectacle lenses or placebo [12][13][14] . Studies have also indicated bifocal and progressive addition spectacle lenses can also slow the progression of myopia in children with near-point esophoria and larger accommodative lags [15][16][17] . Low dose atropine is not readily available as a licensed product in Europe but is accessible through clinical trials, with the recruitment of trial participants dependent on Optometrist referrals [18][19][20] .…”

Section: Introductionmentioning

confidence: 99%

“…A number of contact lens options for managing myopia are also commercially available in Europe and are reported to slow myopia progression by approximately 30% to 60% 13 . These include multifocal contact lenses, frequently fitted ‘off- label’ 21 , novel myopia control lenses (becoming more readily available globally) 22 , and orthokeratology contact lenses.…”

Section: Introductionmentioning

confidence: 99%

Is optometry ready for myopia control? Education and other barriers to the treatment of myopia

2020

View full text Add to dashboard Cite

With the increasing prevalence of myopia there is growing Background: interest in active myopia control. However, the majority of progressive myopes are still prescribed single vision spectacles. This prospective study aims to elucidate the knowledge and attitudes of optometrists toward myopia control, and thereby identify perceived barriers to the implementation of a risk focussed model of myopia management.A series of four focus group discussions were conducted Methods: involving optometrists in different settings and career stages.The key finding to emerge is a disconnect in myopia control Results: knowledge and practices between academic optometrists, final year optometry students and clinicians in practice. Academic faculty believe the optometry curriculum should provide undergraduates with the clinical skills to practise myopia control, however, although students were knowledgeable in relation to myopia associated risk factors, some students had not yet undertaken any practical form of myopia control in their undergraduate degree. Furthermore, students may not receive hands-on myopia control experience during their supervised practice placement, as the majority of clinicians do not offer myopia control treatments, other than to communicate lifestyle advice to modify risk of myopia progression. Clinicians alluded to a lack of availability of myopia control interventions and identified a range of barriers relating to their training, clinical practice and public health challenges, financial, technological and other constraints that affect the implementation of such interventions. It appears optometrists have to yet embrace myopia control Conclusion:as a core element of the clinical eye care service they provide. Education, training, finance, and time restrictions, as well as limited availability of myopia control therapies were among the main perceived barriers to myopia control. This study revealed a distinct need for alignment between optometric training and the public health need for effective myopia control. Keywords 11,2 1,3

show abstract

IMI – Industry Guidelines and Ethical Considerations for Myopia Control Report

Cited by 27 publications

References 173 publications

Global trends in myopia management attitudes and strategies in clinical practice – 2019 Update

Global trends in myopia management attitudes and strategies in clinical practice – 2019 Update

Is optometry ready for myopia control? Education and other barriers to the treatment of myopia

Is optometry ready for myopia control? Education and other barriers to the treatment of myopia

Contact Info

Product

Resources

About